We recently demonstrated that expression of -defensins, the major antimicrobial peptides produced by Paneth cells was severely suppressed in mice with graft-versus-host disease (GVHD). In this study, we found that antibacterial lectin, regenerating islet-derived III (RegIII) was upregulated in villous enterocytes, thus demonstrating the reciprocal control of enteric antimicrobial proteins in GVHD.
Introduction
Allogeneic hematopoietic stem cell transplantation (SCT), a curative therapy for a number of hematologic diseases, is complicated by graft-versus-host disease (GVHD). Particularly, intestinal GVHD is critical for determining the outcome of allogeneic BMT (1) . Recently, regenerating islet-derived 3α (RegIII) is identified as a specific biomarker for intestinal GVHD in human using a large-scale and quantitative proteomic discovery approach (2, 3) . Reg genes constitute a multigene family, which is categorized into four subclasses. RegIII, a homologue of human RegIIIin mice, is preferentially expressed in the small intestine. RegIII have canonical C-type lectin domains that bind to the peptidoglycan, which is an essential component of the bacterial cell wall and thus has direct antimicrobial activity, specifically against Gram-positive bacteria and protects the epithelial barrier function of the intestinal mucosa (4) .
The intestinal microbial communities are actively regulated by Paneth cells through their secretion of antimicrobial peptides. Among them, α-defensins are the most potent antimicrobial peptides that account for 70% of the bactericidal peptide activity released from Paneth cells (5, 6) . We recently found that Paneth cells were targeted by GVHD, resulting in marked reduction in the expression of α-defensins (7) . Thus, it is puzzling why blood levels of RegIII levels are elevated, while α-defensins are downregulated in GVHD. In this study, we evaluated enteric expression of RegIIIat the cellular level in mouse models of bone marrow transplantation (BMT) and found that the major producers of RegIIIwere villous enterocytes, not Paneth cells in GVHD.
Upregulation of RegIII in GVHD was dependent upon MyD88-mediated sensing of the intestinal microflora.
Material and Methods
Mice. Female C57BL/6 (B6: BMT. Mice were transplanted as previously described (9) . In brief, after lethal X-ray total body irradiation (TBI) delivered in 2 doses at 4h intervals, mice were intravenously injected with 5 × 10 6 T-cell depleted-bone marrow (TCD-BM) cells with or without 2 × 10 6 splenic T cells on day 0. Isolation of T cells and T-cell depletion were performed using the T cell isolation kit and anti-CD90-MicroBeads, respectively, and the AutoMACS (Miltenyi Biotec) according to the manufacturer's instructions. In unirradiated model of BMT, B6D2F1 mice were intravenously injected with 12 × 10 7 splenocytes(7, 10). PMV regimen is consisted of polymyxin B (10 5 U/kg), metronidazole (30 mg/kg), and vancomycin (30 mg/kg). Mice were maintained in specific pathogen-free condition and received normal chow and autoclaved hyperchlorinated water (PH 4) for the first 3 wks post-BMT and filtered water thereafter.
The degree of clinical GVHD was assessed weekly by a scoring system which sums changes in five clinical parameters: weight loss, posture, activity, fur texture, and skin integrity (maximum index = 10) as described previously (9) .
Histological and immunohistochemical analysis. For pathological analysis, samples of the small intestine were fixed in 10% neutral-buffered formalin, embedded in paraffin, sectioned, slide mounted, and stained with H&E. Immunohistochemistry was performed as described (11) using rabbit anti-defensin 1 and anti-RegIII (Funakoshi). Histofine Simple Stain MAX PO (Rat) kits and subsequently DAB solution (Nichirei Biosciences) was used to generate brown-colored signals. Slides were then counterstained with hematoxylin. Pictures from tissue sections were taken at room temperature using a digital camera (DP72; Olympus) mounted on a microscope (BX51; Olympus).
Preparation and analysis of isolated mouse crypts. Individual crypts were isolated from the small intestine as previously described (6) . Following fixation and permeabilization, isolated crypts were incubated for 1h with FITC-conjugated anti-Lysozyme (10µg/ml; Dako), followed by incubation for 1h with Allexa Fluor 594-conjugated phalloidin (1U/ml; Invitrogen). Tetramethyl DAPI (5µg/ml; Invitrogen) was used to stain the nucleus. Samples were mounted in Aqua Poly/Mount (Polysciences) and examined with a confocal laser-scanning microscope (LSM510; Carl Zeiss). 
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Results
Reciprocal control of α-defensins and RegIII expression in GVHD
Lethally irradiated B6D2F1 (H-2 b/d ) mice received 5 × 10 6 TCD-BM alone (control group) or TCD-BM plus 2 × 10 6 T cells (GVHD group) from major histocompatibility complex (MHC)-mismatched B6 (H-2 b ) donors on day 0. The allogeneic animals developed severe GVHD, as previously demonstrated(7, 10) (data not shown). Pathological analysis of the small intestine 7d after BMT showed mostly normal architecture in controls, while blunting of villi was observed in the GVHD group ( Fig. 1A) . Confocal cross-sectioning of individual crypts isolated from the small intestine demonstrated Paneth cell loss in mice with GVHD, as previously shown (7) ( Fig. 1B) .
-Defensins are the major antimicrobial peptides produced by Paneth cells (6) .
Immunohistochemical analysis showed that defensin  1 expression was limited in Paneth cells in the crypts of naïve mice (Fig. 1C) . Expression of defensin  1 was preserved in controls but was severely suppressed in mice with GVHD 7d after BMT (Fig. 1C) . In contrast, RegIII expression was markedly increased in villous enterocytes in the GVHD group (Fig. 1D) . It should be noted that major producers of RegIII were not Paneth cells, and there was little expression of defensin  1 in enterocytes in GVHD.
To confirm the differential expression of α-defensins and RegIII, their expression levels in the terminal ileum were evaluated by quantitative real-time PCR analysis. In the GVHD group, expression of defensin- 1 (Defa1) was markedly reduced (Fig. 1E) , while RegIII expression was significantly increased (Fig. 1F) .
RegIII upregulation in GVHD by a mechanism independent upon radiation-induced intestinal tract damage
We determined if increased expression of RegIII in the small intestine correlated with increased serum levels of RegIII. Serum levels of RegIII were not increased in the control group after BMT, whereas those were significantly and constantly elevated in the GVHD group ( Fig. 2A) . We next addressed whether RegIII upregulation could be related to radiation-induced intestinal tract damage using an unirradiated B6 → B6D2F1 model as previously described (7, 10) . Again, serum levels of RegIII were significantly and constantly elevated in the GVHD group to the similar levels observed in the irradiated model (Fig. 2B) .
RegIII upregulation in MHC-matched models of GVHD
We then evaluated if upregulation of RegIII could be observed in clinically relevant, MHC-matched, but minor histocompatibility antigen-mismatched models of BMT. Again, serum levels of RegIII were significantly elevated in the B6 → BALB.B model (Fig. 2C) and the C3H.Sw → B6 model of BMT (Fig. 2D) .
RegIII is induced by the stimulation of intestinal microbes through
MyD88-mediated signaling in intestinal epithelium in GVHD
We investigated mechanisms of upregulation of enteric expression of RegIII in GVHD. Since recognition of commensal microflora by toll-like receptors (TLRs) is required for intestinal homeostasis and RegIIIγ expression is controlled by microorganism-associated molecular patterns that activate MyD88 pathway (12) (13) (14) (15) , we hypothesized that bacterial stimuli through MyD88 pathway could mediate the upregulation of RegIIIin GVHD. To test this hypothesis, wild-type (WT) or MyD88 -/-B6 mice were used as recipients in the C3H.Sw → B6 model of BMT. Clinical GVHD scores were not significantly different between WT and MyD88 -/mice on days 28 and 35 after BMT (Supplemental Figure A) . Nonetheless, serum levels of RegIII were significantly lower in MyD88 -/mice than in WT mice on d28 and d35 after BMT ( Fig.   2E ).
We and others have shown that GVHD induces dramatic alteration in the intestinal microbiota (7, 16, 17) . We therefore hypothesized that upregulated expression of RegIII might be a natural mechanism of adaptation aimed to restore normal intestinal ecology. To evaluate whether modifying the enteric flora using oral antibiotics could inhibit upregulation of RegIII, mice were treated with broad-spectrum antibiotic combination as described with a slight modification (14) . PMV was administered by daily oral gavage from d-14 in the C3H.Sw → B6 model of BMT. It reduced clinical GVHD scores, as previously described (7) (Supplemental Figure B) . Notably, PMV regimen prevented upregulation of RegIII on d28 after BMT (Fig. 2F) .
Induction of RegIIIγ also requires IL-22-mediated signals from innate lymphoid cells (18, 19) . However, serum levels of IL-22 were significantly lower in the GVHD group than in controls on d28 and d35 after BMT in the C3H.Sw → B6 model (Supplemental Figure C) . Gut decontamination with the PMV regimen or the use of MyD88 -/-B6 mice did not change serum levels of IL-22 (data not shown).
Discussion
Epithelial antimicrobial proteins have an essential role in allowing epithelial surfaces to cope with microbial challenges. They include defensins, cathelicidins, C-type lectins such as the Reg family (20) . In this study, we found that enteric expression of -defensins and RegIII was reciprocally controlled in GVHD. This was due to the difference in the major producers of these molecules in GVHD. It has been shown that α-defensins are exclusively produced by Paneth cells, whereas RegIIIγ is produced by both villous enterocytes and Paneth cells in steady state (13, 21) . In GVHD, enterocyte production of RegIII was markedly increased, whereas Paneth cell production of α-defensins was severely suppressed.
Intestinal GVHD is characterized by severe villous atrophy and crypt degeneration. Crypt cell apoptosis is one of the initial lesions and the cardinal features of the intestinal GVHD (22, 23) . Many experimental and clinical evidence favors the idea that crypt cells are the principal focus of the attack by donor T cells and inflammatory cytokines in GVHD (24) . Intestinal stem cells (ISCs) and their niche, Paneth cells reside in the crypts and we have shown that both ISCs and Paneth cells are targeted by GVHD (7, 10) . In contrast, there is little evidence of direct damage to mature villous enterocytes in mild GVHD and damage to mature enterocyte appears only at severe stage, suggesting that these events are secondary to the alterations in crypt cell turnover (22) (23) (24) (25) .
Serum levels of RegIII were increased in an unirradiated model of BMT, demonstrating a mechanism independent upon radiation-induced intestinal tract damage.
These results are consistent with our recent observation that GVHD induces Paneth cell injury and subsequent dysbiosis by a mechanism independent upon conditioning (7) . A recent clinical study demonstrated that low Paneth cell numbers at onset of intestinal GVHD is associated with high risk for non-relapse mortality (26) .
We have shown that MyD88-mediated signaling in host non-hematopoietic cells is required for upregulation of RegIII in villous enterocytes in GVHD. Since severity of GVHD was not altered in MyD88 -/mice as has been shown (27) , downregulation of RegIII was not secondary to amelioration of GVHD. These results suggest a potential lack of reliability of RegIII as a marker for GVHD and argue against a role for it in the pathophysiology of GVHD. Administration of the broad-spectrum antibiotic combination PMV markedly decreased serum levels of RegIII in GVHD. These results are consistent with previous studies demonstrating that RegIIIγ expression is controlled by microorganism-associated molecular patterns that activate MyD88 pathway in non-hematopoietic cells in steady state and in bacterial infection (12) (13) (14) (15) 17) . Sensitivity of RegIIIγ as a biomarker of intestinal GVHD may be reduced when intensive and broad antibiotics are administered.
We and others have shown that development of intestinal GVHD induced marked dysbiosis in the intestinal flora in mice and human (7, 16, 17, 28) . Although dominantly expanded bacteria in GVHD differs at institutions (7, 16, 17) , we found the prominent outgrowth of Gram-negative bacteria, Escherichia coli (E. coli) in the intestinal flora in GVHD (7) , thus supporting the previous findings that Gram-negative bacteria, but not Gram-positive bacteria, induces RegIII expression (14, 29) . Thus, it is tempting to assume that enhanced production of RegIII is a natural adaptation mechanism for the dysbiosis in GVHD. Paneth cell metaplasia is also observed in the colon of GVHD patients probably as an adaptation mechanism for Panrth cell loss and the dysbiosis(30).
We have shown that Paneth cell-derived α-defensin production is markedly inhibited in GVHD that have selective bactericidal activity mostly against Gram-negative bacteria (7, 31, 32) . On the other hand, the antibacterial activity of RegIII is likely restricted to Gram-positive bacteria because of their accessibility to peptidoglycan on the cell surface of Gram-positive bacteria (4) . Thus, bacteria belonging to different classes may battle against each other by stimulating innate antimicrobial mechanisms that selectively inactivate specific bacteria in the mammalian gut, and dramatic decrease in a ratio of α-defensins to RegIIIproduction may be in tune with overwhelming outgrowth of Gram-negative bacteria.
RegIIIγ mRNA expression also requires IL-22-mediated signals from ILCs (18, 19) . However, IL-22 was reduced in GVHD in our study. Hanash et al. recently demonstrated that IL-22 producing innate lymphoid cells were eliminated in GVHD; however, RegIIIγ was still expressed in GVHD in IL-22 -/mice, suggesting that RegIIIγ expression was upregulated by IL-22 independent pathways in the presence of minimum amounts of IL-22 in GVHD (33) .
Recently, RegIII is identified as a specific biomarker for intestinal GVHD in human using a large-scale and quantitative proteomic discovery approach(2, 3). Our results support these studies and give mechanistic insights. These new insights will help to understand pathophysiology of GVHD in the context of host-microbe interaction and to establish new therapeutic strategies that can improve clinical outcome of allogeneic SCT. 
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